Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
H HaraM A Moskowitz

Abstract

Infarct volume and edema were assessed after transient focal ischemia in mice lacking neuronal nitric oxide synthase (NOS) gene expression. With use of an 8-0 coated monofilament, the middle cerebral artery (MCA) of mutant (n = 32) and wild-type mice [SV-129 (n = 31), C57Black/6 (n = 18)] were occluded for 3 h and reperfused for up to 24 h. Regional CBF (rCBF), neurological deficits, water content, and infarct volume were examined in all three strains. rCBF, blood pressure, and heart rate did not differ between groups when measured for 1 h after reperfusion. Neurological deficits were less severe in mutant mice after MCA occlusion. Brain water content at 3 h after reperfusion and infarct volume at 24 h after reperfusion were greater in wild-type mice. These data indicate that genetic deletion of neuronal NOS confers resistance to focal ischemic injury in a reperfusion model. The findings agree with previous studies showing that tissue injury is less extensive after both permanent MCA occlusion and global ischemia in mice lacking neuronal NOS gene expression. Hence, NO may play a pivotal role in the pathogenesis of ischemic brain damage.

References

Dec 18, 1992·Science·J S StamlerJ Loscalzo
Jan 1, 1992·Neuron·D S Bredt, S H Snyder
Sep 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S YamamotoD J Reis
Sep 1, 1992·Annals of Neurology·T M DawsonS H Snyder
Jun 1, 1992·Stroke; a Journal of Cerebral Circulation·D XueA M Buchan
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L DawsonS H Snyder
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Mar 1, 1990·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·R A SwansonF R Sharp
Nov 12, 1991·European Journal of Pharmacology·J P NowickiB Scatton
Nov 1, 1990·Archives of Neurology·J M Hallenbeck, A J Dutka
Sep 1, 1990·Stroke; a Journal of Cerebral Circulation·S ImaizumiP H Chan
Jan 1, 1989·Chemico-biological Interactions·H A Kontos
May 1, 1986·Stroke; a Journal of Cerebral Circulation·J B BedersonH Bartkowski
Jan 1, 1994·Progress in Neurobiology·S R Vincent
Jan 1, 1994·Medicinal Research Reviews·J F Kerwin, M Heller
Mar 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C IadecolaN A Lassen
Jan 1, 1994·Sheng li ke xue jin zhan [Progress in physiology]·J Q CuiH X Wagn
Sep 23, 1994·Cell·C Nathan, Q W Xie
Nov 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T YoshidaM A Moskowitz
Jan 1, 1994·Annual Review of Biochemistry·D S Bredt, S H Snyder
Jun 1, 1995·Stroke; a Journal of Cerebral Circulation·A SlivkaL Horrocks
Oct 1, 1993·Journal of Neurosurgical Anesthesiology·S AshwalW J Pearce
Jul 1, 1993·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·F C BaroneR N Willette
Nov 1, 1996·Stroke; a Journal of Cerebral Circulation·S P Ringel

❮ Previous
Next ❯

Citations

Jul 14, 2010·Cellular and Molecular Neurobiology·Hiroto UchidaTsutomu Araki
Jun 16, 2009·Neurotoxicity Research·Gjumrakch AlievValentin Bragin
Jun 7, 2005·Experimental Neurology·Dominique LerouetIsabelle Margaill
May 22, 2002·Neurochemistry International·Vemuganti L Raghavendra Rao
Nov 22, 2000·Brain Research. Brain Research Protocols·N Panahian, M D Maines
Mar 6, 2012·Nature Neuroscience·Long-Jun WuDavid E Clapham
Jun 29, 1999·British Journal of Pharmacology·S ParmentierM Plotkine
Dec 1, 2007·Cell Death and Differentiation·T KudoM Takeda
Oct 29, 2003·Antioxidants & Redox Signaling·Taku Sugawara, Pak H Chan
Jan 15, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A O Caggiano, R P Kraig
Jun 22, 2002·Annals of the New York Academy of Sciences·Philip K LiuAlex Valadka
Aug 23, 2011·The Journal of Pharmacology and Experimental Therapeutics·Li YangThomas J Abbruscato
Dec 21, 2006·Molecular and Cellular Biology·Shinichi KondoKazunori Imaizumi
May 20, 1999·Annual Review of Pharmacology and Toxicology·A J HobbsS Moncada
Apr 14, 2006·Neuroimmunomodulation·Olaf Schulte-HerbrüggenAndreas Meisel
Mar 6, 2010·Journal of Neuroinflammation·Denise HarhausenGeorge Trendelenburg
Nov 26, 2010·Experimental & Translational Stroke Medicine·Kana HyakkokuHideaki Hara
Jan 7, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lee J MartinMargaret Wong
Feb 15, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S HongG J Seong

❮ Previous
Next ❯

Methods Mentioned

BETA
scintillation spectrometry

Software Mentioned

Statview
MacLab
Bioquant

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.